Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 1465 Multiplex imaging identif...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
1465 Multiplex imaging identifies unique immunophenotypic and spatial characteristics associated with response to immune checkpoint inhibitors (ICIs) in metastatic urothelial cancer (mUC)

1465 Multiplex imaging identifies unique immunophenotypic and spatial characteristics associated with response to immune checkpoint inhibitors (ICIs) in metastatic urothelial cancer (mUC)

Bibliographic Details
Main Authors: Padmanee Sharma, Seunghee Kim-Schulze, Justin David, John-William Sidhom, Sacha Gnjatic, Guray Akturk, Matthew Galsky, Saurabh Gupta, Jonathan Anker, Sudeh Izadmehr
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 1309 Deep learning reveals predictive immune signature of response to checkpoint blockade in multiplexed spatial immunohistochemistry data
    by: Padmanee Sharma, et al.
    Published: (2023-11-01)
  • The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)
    by: Minira Aslanova, et al.
    Published: (2024-07-01)
  • Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program
    by: Fernando Sabino M. Monteiro, et al.
    Published: (2021-05-01)
  • Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
    by: Huan Wang, et al.
    Published: (2023-08-01)
  • Expanding Treatment Options in mUC and mRCC
    by: Richard Cathomas
    Published: (2022-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs